Immatics N.V. (IMTX) vs Janux Therapeutics, Inc. (JANX)
- Immatics N.V. IMTX 6.72 −5.88%
- Janux Therapeutics, Inc. JANX 16.49 −4.79%
Immatics N.V. and Janux Therapeutics, Inc. are both Biotechnology companies. Immatics N.V. and Janux Therapeutics, Inc. are of similar size ($1.1B and $1.1B). Janux Therapeutics, Inc. grew revenue faster over the last twelve months: 83.9% against −65.0%. Janux Therapeutics, Inc. has the higher net margin (−427.5% vs −489.4%) and the higher return on invested capital (0.00% vs −84.8%). Across the 15 metrics below, Janux Therapeutics, Inc. leads on 12 and Immatics N.V. on 3.
Valuation
Profitability
| Metric | IMTX | JANX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (536.26%) | (598.15%) | 0.00% |
| Net margin | (489.35%) | (427.47%) | 0.00% |
| Free cash flow margin | (488.01%) | (174.69%) | 0.00% |
| Return on equity | (48.53%) | (10.70%) | (56.36%) |
| Return on assets | (39.83%) | (10.06%) | (48.04%) |
| Return on invested capital | (84.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack